Weekly Executive & Director Moves (June 23)

by | Jun 23, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

BHIL, CANO, HHS, SHLS, VFC

CFO

AKBA, BCYC, CG, CHS, EA, GRPH, HOV, IART, VNCE

Directors

AES, AGIO, AGLE, AHCO, AMBC, BASE, BCLI, BE, BHC, BHIL, BJ, CRGE, CROX, CTOS, CZFS, DASH, DRRX, ELDN, EWTX, EXLS, FNCH, GLW, GO, HEAR, HHS, HQY, HSII, JSPR, KRNY, KRON, LFMD, ME, MIR, NOGN, NVRI, NXU, OKTA, PGC, PVBC, ROC, ROCC, SPCE, SST, ST, TH, THM, TSHA, VFC, WRAP

 

CEO Moves

BENSON HILL INC (BHIL)
Leaving: CEO – Matthew B Crisp ( 1.8 yrs; -67.1% TSR)
Replaced by: Adrienne Elsner

ADRIENNE ELSNER Career Highlights Director Ms. Elsner served as President, Chief Executive Officer, and Director of Charlotte’s Web Holding, Inc., a leader in hemp-derived CBD extract products, from 2019 to 2021. From 2015 to 2018, she served as President, U. S. Snacks, Kellogg Company, a manufacturer and marketer of convenience foods. From 1992 to 2015, Ms. Elsner served in several increasingly s…read full bio

CANO HEALTH INC (CANO)
Leaving: CEO – Marlow Hernandez ( 2.0 yrs; -66.6% TSR)
Replaced by: Mark Kent

Prior to joining Cano Health, Mr. Kent founded three startup healthcare companies which help provider practices operate successfully within value-based arrangements: Care Management Resources, Total Health Medical Centers and Your Partners in Health. He has also held numerous senior executive roles, including having served as CEO of Women’s Health Care Hospital in read full bio

SHOALS TECHNOLOGIES GROUP INC (SHLS)
Leaving: CEO – Jeffery Tolnar ( .3 yrs; )
Replaced by: Brandon Moss

Mr. Moss, age 44, will join the Company from Southwire Company, one of North America’s largest wire and cable developers, manufacturers and suppliers, where he has served in various positions including most recently as President, Tools, Components & Assembled Solutions Business since 2014. In that position, among other responsibilities, he led an autonomous business unit and…read full bio

CFO Moves

AKEBIA THERAPEUTICS INC (AKBA)
Leaving: CFO – David A Spellman ( 3.0 yrs; -52.0% TSR)
Replaced by: Ellen Snow

Ms. Snow, age 51, has served as the Chief Accounting Officer and Principal Accounting Officer of Pear Therapeutics, Inc., a digital therapeutics company, since March 2021. Prior to joining Pear Therapeutics, Inc., Ms. Snow served as the Chief Accounting Officer and Principal Accounting Officer of AlerisLife Inc., a senior living and lifestyle services company, formerly known as Five Star Senior Li…read full bio

CARLYLE GROUP INC (CG)
Leaving: CFO – Curtis L Buser ( 9.3 yrs; 4.3% TSR)
Replaced by: John C Redett

John C. Redett, 55, Head of Global Financial Services, will become Chief Financial Officer and Head of Corporate Strategy, effective October 1, 2023. Mr. Redett joined Carlyle in 2007 as an investor on the Global Financial Services team. He has served as the sole Head of Global Financial Services since 2020 and was the Co-Head of Global Financial Services from 2016 to 2020. Prior to joining Carlyl…read full bio

CHICO’S FAS INC (CHS)
Leaving: CFO – Patrick J Guido ( 1.8 yrs; -7.9% TSR)
Replaced by: David M Oliver

David M. Oliver is Senior Vice President – Finance, Controller and Chief Accounting Officer of Chico’s FAS, Inc., having joined the Company in March 2012. Mr. Oliver has held multiple leadership roles within Chico’s FAS, Inc. leading to his current position. He initially joined the Company as Vice President – Finance and Controller, followed by the role of Group Vice President – Finance, Controlle…read full bio

ELECTRONIC ARTS INC (EA)
Leaving: CFO – Chris Suh ( 1.3 yrs; -2.7% TSR)
Replaced by: Stuart Canfield

A 20 year veteran of EA, Mr. Canfield, age 44 has held several positions of increasing responsibility within EA’s finance organization since joining EA in 2003, including Senior Vice President, Enterprise Finance and Investor Relations from March 2023 to June 2023; Senior Vice President, Finance – Head of Global Financial Plann…read full bio

GRAPHITE BIO INC (GRPH)
Leaving: CFO – Alethia Young ( 1.2 yrs; -52.4% TSR)
Replaced by: Joshua Lehrer-Graiwer

Josh Lehrer, M.Phil., M.D., FACC has served as our President and Chief Executive Officer and on our board of directors since April 2020. From October 2013 to April 2020, Dr. Lehrer held various leadership roles at Global Blood Therapeutics, Inc., including chief medical officer. From September 2009 to October 2013, Dr. Lehrer served in leadership roles a…read full bio

HOVNANIAN ENTERPRISES INC (HOV)
Leaving: CFO – J Larry Sorsby ( 27.8 yrs; .1% TSR)
Replaced by: Brad G O’Connor

Brad G. O’Connor 52 Senior Vice President, Treasurer and Chief Accounting Officer 2004 Mr. Hovnanian has been Chief Executive Officer since July 1997 after being appointed President in 1988 and Executive Vice President in 1983….read full bio

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
Leaving: CFO – Mathieu P. Aussermeier ( .3 yrs; )
Replaced by: Lea Daniels Knight

Ms. Knight, 52, previously served as Executive Vice President of Business Finance at Booz Allen Hamilton, from September 2022 to June 2023, and was responsible for providing strategic and financial leadership. Prior to her role at Booz Allen Hamilton, she worked for 18 years in the pharmaceuticals sector of Johnson & Johnson (and its subsidiaries), most recently serving as Chief Financial O…read full bio

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
Leaving: CFO – Jeffrey Mosebrook ( .3 yrs; )
Replaced by: Lea Daniels Knight

Ms. Knight, 52, previously served as Executive Vice President of Business Finance at Booz Allen Hamilton, from September 2022 to June 2023, and was responsible for providing strategic and financial leadership. Prior to her role at Booz Allen Hamilton, she worked for 18 years in the pharmaceuticals sector of Johnson & Johnson (and its subsidiaries), most recently serving as Chief Financial O…read full bio

VINCE HOLDING CORP (VNCE)
Leaving: CFO – Amy “Levy” Trooskin ( .3 yrs; )
Replaced by: Michael Hand

Mr. Hand is a seasoned corporate finance executive with over 40 years of financial, operations and general business experience in both public and private organizations. The majority of his career has been with growing consumer goods companies including retail, wholesale, e-commerce businesses. He has led financial and accounting teams at Marc Jacobs, Cole Haan, Coach, and Movado as well as Soth…read full bio

Director Joins

AGIOS PHARMACEUTICALS INC (AGIO)
Jeffrey D Capello

Jeffrey Capello will begin serving a member of our board of directors effective as of the date of the Annual Meeting. Mr. Capello has served as the managing partner of Monomoy Advisors, a financial advisory firm, since April 2021. Mr. Capello served as the Executive Vice President and Chief Financia…read full bio

AMBAC FINANCIAL GROUP INC (AMBC)
Kristi Ann Matus

Ms. Matus is a new director nominee. From October 2020 until July 2022, she was the Chief Financial Officer and Chief Operating Officer of Buckle Agency LLC, a digital financial services company which provides insurance products and solutions for the rapidly growing ride-share and delivery segmen…read full bio

AMBAC FINANCIAL GROUP INC (AMBC)
Michael D Price

Mr. Price is a new director nominee. Mr. Price served as President and Chief Executive Officer of Platinum Underwriters Holdings, Ltd. from 2005 until its acquisition by RenaissanceRe Holdings Ltd in 2015. Platinum Underwriters Holdings provided property and casualty reinsurance coverages to insu…read full bio

BENSON HILL INC (BHIL)
Richard L Mack

Richard Mack is an experienced, entrepreneurial business executive with significant expertise in the finance and agricultural industry. Mr. Mack was a founding executive of The Mosaic Company, holding various senior executive posts from its formation in 2004. From June 2014 through Janu…read full bio

BLOOM ENERGY CORP (BE)
Cynthia J Warner

Warner currently serves on the Board of Directors for Chevron and is Lead Independent Director for Sempra Energy. She is also a member of the Columbia University Advisory Board for the Center for Global Energy Policy (CGEP), the National Petroleum Council, and the Vanderbilt University School of …read full bio

BRAINSTORM CELL THERAPEUTICS INC (BCLI)
Nir Naor

Nir Naor has over 20 years of global work experience as CFO and senior finance leader, with the majority of his career spent at U.S. and European corporations. He has a broad background that includes large pharma and biotech, and has overseen organizations with up to $2.5B in sales and $1B in ann…read full bio

CHARGE ENTERPRISES INC (CRGE)
Jacky Wu

Mr. Wu, age 40, is Executive Vice President, Chief Financial Officer and Treasurer of DigitalBridge (formerly Colony Capital, NYSE: DBRG), a digital infrastructure investment firm. Prior to joining DigitalBridge in March 2020, Mr. Wu served as Executive Vice President and Chief Financial Officer …read full bio

CORNING INC (GLW)
Thomas D French

Mr. French retired as a senior partner of McKinsey & Company in December 2019, and currently is Senior Partner Emeritus. During his 33-year career with McKinsey, he served leading technology-driven industrial companies on issues of strategy, marketing, corporate governance, and organization d…read full bio

CUSTOM TRUCK ONE SOURCE INC (CTOS)
Ryan McMonagle

Ryan McMonagle Mr. McMonagle, age 45, became the Chief Executive Officer of Custom Truck One Source on March 20, 2023. He joined Custom Truck as CFO in 2015, following Blackstone’s investment. He became Chief Operating Officer of Custom Truck One Source in 2017 and President in 2021. Previously, Mr….read full bio

INTERNATIONAL TOWER HILL MINES LTD (THM)
Edel Tully

Dr. Tully is a business leader with 20 years of experience in the precious metals market. She is currently the Head of Communications and Financial Markets Development Lead at the London Bullion Market Association (LBMA). Edel spent 10 years at UBS where she was most recently Global Head Precious…read full bio

JASPER THERAPEUTICS INC (JSPR)
Scott C Brun

Dr. Brun, age 55, is currently President at Gold Mast Consulting, LLC, an advisory firm he founded in 2019 to provide technical advice and strategic guidance related to biopharmaceutical research and development, pipeline portfolio management, commercialization of new therapeutics and strategic c…read full bio

KEARNY FINANCIAL CORP (KRNY)
Melvina Wong-Zaza

Ms. Wong-Zaza currently holds the position of Director, Strategic Global Clients at CMA-CGM Group, a global shipping company where she provides executive leadership and innovative solutions to global clients in Asia, Europe and USA markets.  Her career spans over 30 years in senior managemen…read full bio

LIFEMD INC (LFMD)
William J Febbo

Mr. Febbo is Chief Executive Officer and a Director of OptimizeRx Corporation (Nasdaq: OPRX). OptimizeRx is a leading provider of digital point-of-care technology solutions that help patients start and stay on therapy. For more than 25 years Mr. Febbo has built and managed health services and fin…read full bio

NOGIN INC (NOGN)
Shahriyar Rahmati

Mr. Rahmati will serve as a Class III director of the Board for a term ending at the 2025 annual meeting of stockholders of the Company. Shahriyar Rahmati, 46, has served as the Company’s Chief Financial Officer and Chief Operating Officer since August 2022. Mr. Rahmati has over twenty years of expe…read full bio

NOGIN INC (NOGN)
Arthur Stark

Arthur Stark has served on our Board since June 2023. Mr. Stark has over forty-five years of experience in various executive-level roles across several industries. Mr. Stark currently serves as Chairman of Stark Enterprises, providing advisory services and to a broad array of companies. Additionally…read full bio

PEAPACK GLADSTONE FINANCIAL CORP (PGC)
Patrick Campion

Mr. Campion, age 62, served as Chief Executive Officer of HSBC’s US Private Bank from 2007 to 2016.  Prior to that position, he served as U.S. Wealth Management Head at Deutsche Bank from 2005 to 2007 and as Manager of NY-CT at Citi Private Bank from 1999 to 2005.  Mr. Campion cur…read full bio

ROC ENERGY ACQUISITION CORP (ROC)
Charles Richard Vermillion Jr

C. Richard Vermillion has been a director of DTI since 2016. He has also served as the Chairman and CEO of MV Partners, Inc., a private investment vehicle, since 1996. During that time, Mr. Vermillion has invested in and served on the boards of several companies, incl…read full bio

ROC ENERGY ACQUISITION CORP (ROC)
Robert Wayne Prejean

Wayne Prejean has been the Chief Executive Officer of DTI since 2013. Mr. Prejean has more than 40 years of industry experience, having begun his career in 1979 working in field operations in the Gulf of Mexico. He spent the next 20 years employed by firms s…read full bio

ROC ENERGY ACQUISITION CORP (ROC)
Jack D Furst

Jack Furst has been a director of DTI since 2012. He is also the founder of Oak Stream Investors, a private investment firm founded in 2008 which makes investments in real estate, oil and gas, fixed income securities and public and private equities. Mr. Furst joined H…read full bio

TARGET HOSPITALITY CORP (TH)
Alejandro Hernandez

Mr. Hernandez is an accomplished leader with over 20 years of experience in the power, utilities, renewables, nuclear, industrials and data center infrastructure sectors. From November 2021 through May 2023, he served as President, Chief Executive Officer and director Talen Energy Corporation, on…read full bio

Director Exits

23ANDME HOLDING CO (ME)
Evan Lovell ( 3.3 yrs; -45.8% TSR)

ADAPTHEALTH CORP (AHCO)
Stephen P Griggs ( 2.3 yrs; -41.0% TSR)

AEGLEA BIOTHERAPEUTICS INC (AGLE)
Armen Shanafelt ( 9.5 yrs; -44.0% TSR)
Committees: Nominating (and Governance)

AEGLEA BIOTHERAPEUTICS INC (AGLE)
V Bryan Lawlis ( 4.9 yrs; -57.2% TSR)
Committees: Audit

AEGLEA BIOTHERAPEUTICS INC (AGLE)
Marcio Souza ( 2.0 yrs; -84.5% TSR)
Committees: Compensation, Nominating (and Governance)

AGIOS PHARMACEUTICALS INC (AGIO)
Paul J Clancy ( 9.8 yrs; -.7% TSR)
Committees: Audit, Compensation & People

BAUSCH HEALTH COMPANIES INC (BHC)
Argeris N Karabelas ( 7.0 yrs; -17.0% TSR)
Committees: Science and Technology, Special Transactions Committee, Talent and Compensation

BAUSCH HEALTH COMPANIES INC (BHC)
Richard U De Schutter ( 6.5 yrs; -12.1% TSR)
Committees: Finance and Transactions, Special Transactions Committee, Talent and Compensation

BENSON HILL INC (BHIL)
Matthew B Crisp ( 1.8 yrs; -67.1% TSR)

BRAINSTORM CELL THERAPEUTICS INC (BCLI)
Malcolm S Taub ( 14.3 yrs; 3.9% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

COUCHBASE INC (BASE)
Edward T Anderson ( 1.9 yrs; -24.8% TSR)

CROCS INC (CROX)
Tracy Gardner ( 2.0 yrs; 4.0% TSR)
Committees: Compensation

DOORDASH INC (DASH)
Stanley J Meresman ( 4.5 yrs; -28.3% TSR)

DURECT CORP (DRRX)
Dave Hoffmann ( 20.5 yrs; -7.8% TSR)
Committees: Audit, Compensation

EDGEWISE THERAPEUTICS INC (EWTX)
Kenneth Harrison ( 3.8 yrs; -42.2% TSR)

ELEDON PHARMACEUTICALS INC (ELDN)
Gary A Lyons ( 6.1 yrs; -48.7% TSR)
Committees: Audit, Compensation

EXLSERVICE HOLDINGS INC (EXLS)
Anne Elizabeth Minto ( 10.3 yrs; 17.1% TSR)
Committees: Compensation, Compensation and Talent Management, Nominating (and Governance)

FINCH THERAPEUTICS GROUP INC (FNCH)
Nicholas Haft ( 3.3 yrs; -68.5% TSR)

GROCERY OUTLET HOLDING CORP (GO)
Norman S Matthews ( 8.7 yrs; -1.7% TSR)
Committees: Compensation, Nominating (and Governance)

HARTE HANKS INC (HHS)
Brian Linscott ( 2.0 yrs; 3.5% TSR)

HEALTHEQUITY INC (HQY)
Ian Sacks ( 19.2 yrs; 14.9% TSR)
Committees: Audit and Risk , cybersecurity and technology, Cyber Subcommittee, Nominating (and Governance), Nominating, Governance and Corporate Sustainability

KRONOS BIO INC (KRON)
Marianne De Backer ( 2.4 yrs; -69.5% TSR)

LIFEMD INC (LFMD)
Stefan Galluppi ( 5.2 yrs; 13.1% TSR)

MIRION TECHNOLOGIES INC (MIR)
Jo Natauri ( 1.7 yrs; -12.3% TSR)

OKTA INC (OKTA)
Patrick W Grady ( 9.1 yrs; 20.7% TSR)
Committees: Audit, Compensation

PROVIDENT BANCORP INC (PVBC)
Jay E Gould ( 3.7 yrs; -9.8% TSR)
Committees: Compensation, Nominating (and Governance)

RANGER OIL CORP (ROCC)
Kevin Cumming ( 2.4 yrs; 69.7% TSR)
Committees: Compensation and Benefits, Nominating (and Governance)

RANGER OIL CORP (ROCC)
Joshua Schmidt ( 2.4 yrs; 69.7% TSR)
Committees: Compensation and Benefits, Reserves

RANGER OIL CORP (ROCC)
Mr. Garrett Chunn ( 1.1 yrs; 6.5% TSR)

RANGER OIL CORP (ROCC)
Richard Alan Burnett ( 1.7 yrs; 39.4% TSR)
Committees: Audit, Compensation and Benefits

RANGER OIL CORP (ROCC)
Edward Geiser ( 2.4 yrs; 69.7% TSR)
Committees: Compensation and Benefits, Nominating (and Governance)

RANGER OIL CORP (ROCC)
Darrin J Henke ( 2.8 yrs; 58.7% TSR)

RANGER OIL CORP (ROCC)
Tim W Gray ( 2.4 yrs; 69.7% TSR)
Committees: Nominating (and Governance)

TAYSHA GENE THERAPIES INC (TSHA)
Paul B Manning ( 3.3 yrs; -71.2% TSR)

TURTLE BEACH CORP (HEAR)
Brian Stech ( 1.2 yrs; -37.5% TSR)
Committees: Compensation

VIRGIN GALACTIC HOLDINGS INC (SPCE)
Evan Lovell ( 3.7 yrs; -21.0% TSR)
Committees: Safety

WRAP TECHNOLOGIES INC (WRAP)
Kimberly C Sentovich ( 2.2 yrs; -49.9% TSR)
Committees: Audit, Nominating (and Governance), Special Executive Search

 

Recent Analysis

Daily SPAC Update – May 24, 2024

QRDO To Liquidate at $10.96. ShoulderUp Extends with 1.1M Redemptions. BFAC Extension Vote. Churchill Investor Deck. DIST Merger Agreement.

Daily SPAC Update – May 23, 2024

MAQC + Immersed Inc. Deal Terminated. GPAC Deal Vote Set. IVCB Extends w/ 2.1M Redemptions. CVII Investor Deck. PWUP Redemption Agreement.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.